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Background: The role of uncoupling proteins (UCP) in the brain is unclear.
Results: UCPs, present in astrocytes, mediate the intramitochondrial acidification leading to a decrease in mitochondrial ATP
production.
Conclusion: Astrocyte pH regulation promotes ATP synthesis by glycolysis whose final product, lactate, increases neuronal
survival.
Significance:We describe a new role for a brain uncoupling protein.
Brain activity is energetically costly and requires a steady and
highly regulated flowof energy equivalents betweenneural cells.
It is believed that a substantial share of cerebral glucose, the
major source of energy of the brain, will preferentially bemetab-
olized in astrocytes via aerobic glycolysis. The aim of this study
was to evaluate whether uncoupling proteins (UCPs), located in
the inner membrane of mitochondria, play a role in setting
up the metabolic response pattern of astrocytes. UCPs are
believed to mediate the transmembrane transfer of protons,
resulting in the uncoupling of oxidative phosphorylation from
ATP production. UCPs are therefore potentially important reg-
ulators of energy fluxes. The main UCP isoforms expressed in
the brain are UCP2, UCP4, and UCP5. We examined in partic-
ular the role of UCP4 in neuron-astrocyte metabolic coupling
and measured a range of functional metabolic parameters
including mitochondrial electrical potential and pH, reactive
oxygen species production, NAD/NADH ratio, ATP/ADP ratio,
CO2 and lactate production, and oxygen consumption rate. In
brief, we found that UCP4 regulates the intramitochondrial pH
of astrocytes, which acidifies as a consequence of glutamate
uptake, with the main consequence of reducing efficiency of
mitochondrial ATP production. The diminished ATP produc-
tion is effectively compensated by enhancement of glycolysis.
This nonoxidative production of energy is not associated with
deleterious H2O2 production.We show that astrocytes express-
ing more UCP4 produced more lactate, which is used as an
energy source by neurons, and had the ability to enhance neu-
ronal survival.
The uncoupling phenomenon of respiration from ATP pro-
duction in favor of the production of heat (1) has been well
described for the uncoupling protein 1 (UCP1, thermogenin)2
(2, 3). This phenomenon is controlled by the sympathetic nerv-
ous system and ismainly present in specific tissues dedicated to
the production of heat, such as brown adipose tissue.
The common term “uncoupling protein” is a legacy of the
analysis of sequence homology with UCP1. It is used for other
UCP isoforms whose role is less established and not necessarily
related to heat production. As far as UCP2 is concerned, its role
is related to temperature control (4) and regulation of reactive
oxygen species (ROS) (5) in the tissues studied. UCP3 expres-
sion correlates with free fatty acid production (6) with a decou-
pling role primarily in muscle (7); its expression is marginal in
brain (8). The role of UCP4 and UCP5 is still largely unknown.
In brain, UCP4 and 5 mRNA levels are modulated by diet or
temperature changes (9). A role in the regulation of ROS has
been described in neural cells (10, 11).
Neurons and astrocytes present different metabolic profiles
(12). Neurons are highly oxidative, producing ROS, whereas
astrocytes are predominantly glycolytic. In the brain, a role in
ROS and temperature control have been described for UCP2
(4). UCP4 and UCP5 are well expressed in the brain (13, 14),
and roles in ROS and calcium level regulation (10, 15) have been
described. In terms of brain cellular localization, immunocyto-
chemistry has revealed that UCP4 is mainly expressed in neu-
rons and less so in astrocytes (16). UCP5 is present in neuronal
cell lines (17, 18); in the rodent brain, UCP5 expression is
observed in the dorsomedial hypothalamic nucleus, hippocam-
pus, paraventricular thalamic nucleus, mediodorsal thalamic
nucleus, and ventromedial hypothalamus (13, 19).
In summary, only limited information is currently available
regarding the role of UCPs in the brain, with the main observa-
tions with a cellular resolution being limited to neurons. In this
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study, we have investigated the roles of UCP4 and UCP5 in
astrocytes, a cell type central to brain energy metabolism.
We have previously shown (20) that uptake into astrocytes of
neuronally released glutamate results in an intramitochondrial
pH decrease in astrocytes rapidly reducing the effectiveness of
the oxidative phosphorylation. In the present report, we show
that this effect of glutamate involves UCP4. Indeed, we
observed that the decrease in oxidative efficiency following glu-
tamate uptake into astrocytes is controlled by UCP4, which
reduces mitochondrial respiration by lowering the intramito-
chondrial pH. Reducing mitochondrial efficiency promotes
aerobic glycolysis in astrocytes. Lactate produced through gly-
colysis can be used by neurons as an energy substrate consistent
with the astrocyte-neuron lactate shuttle (21). These results
indicate that UCP4 plays a key role in astrocyte-neuron meta-
bolic coupling (12).
EXPERIMENTAL PROCEDURES
Primary Culture of Astrocytes—Primary cultures of cortical
astrocytes were prepared from newborns (1–2 days old) Swiss
Albino mice (OF1; Charles River Laboratories) as previously
described (22). The cells were seeded at a density of105 cells/
cm2. Depending on the experiments, the cells were seeded on
35-mm Petri dishes or multiwell plates of 6, 12, 24, or 48 wells.
The plateswere incubated at 37 °C in an atmosphere containing
5% CO2 and 95% air. The cells were rinsed 3–5 days after seed-
ing, and the medium was changed twice a week until cells
reached confluency at 21 days in vitro. Experiments were per-
formed on confluent cells.
Primary Cultures of Neurons and Co-culture—Primary cul-
tures of cortical neurons were prepared from embryonic day 17
OF1mice embryos (Charles River Laboratories). Pregnantmice
were sacrificed by cervical dislocation. The abdomen was
opened, and the placenta containing the embryos was removed
and put in a Petri dish. The embryos were rapidly recovered,
and the cut heads were placed in Petri dish containing 25 ml of
ice-cold Hanks’ buffered salt solution supplemented with pen-
icillin and streptomycin. The embryo brains were separated
from the skulls, and olfactory bulbs, striata, hippocampi, and
meninges were removed. The isolated cortices were minced in
2-mm2 pieces and incubated at 37 °C for 30 min in a solution
containing papain 20 units/ml (Worthington Biochemical), 1
mM L-cysteine, 0.5 mM EDTA, and 100 units/ml DNase (Wor-
thington Biochemical). Papain activity was then inhibited by
addition of FCS. Any traces of papain were removed by keeping
the cells sedimenting and removing the supernatant. Cell pellet
was resuspended in Neurobasal medium (21103049;
Invitrogen) supplemented with penicillin-streptomycin, B27
(17504044; Invitrogen), and GlutaMAX (35050038; Invitro-
gen), and single-cell suspension was obtained by repeated
mechanical trituration. The cellular debris was removed by
centrifugation at 200  g for 5 min. The supernatant was dis-
carded, and the cell pellet was carefully resuspended in pre-
warmed 5 ml supplemented Neurobasal medium. Cells were
plated at an average density of 5  104 cells/cm2 on 20-mm
diameter glass coverslips previously coated overnight with 25
mg/liter polyornithine and rinsed three times with sterile water
the day of dissection. Neurons were maintained at 37 °C in a
humidified atmosphere containing 5% CO2 and 95% air and
were used at day in vitro 14. At 21 days, when astrocytes were
confluent, medium was exchanged for Neurobasal medium
supplemented with GlutaMAX and B27 without antioxidant
(B27 minus AO) (10889038; Invitrogen). 24 h later, the co-cul-
ture was initiated by transferring 12-day-old neurons grown on
coverslips on top of the astrocyte layer culture. The coverslips
with neurons were placed in such a way that neurons were
facing astrocytes separated by a 3-mm gap created by three
paraffin beads attached to the coverslip. The small gap created
by the three paraffin beads was sufficient to avoid any contact
between the two cell types, and thus to avoid astrocytic contam-
ination of the neuronal culture, but allowed the exchange of
medium. Viability experiments were performed 48 h later.
Quantitative Polymerase Chain Reaction—RNA extraction
was performed with the RNeasy mini kit from Qiagen as indi-
cated in the manufacturer’s instruction. RT reactions were
done with the High Capacity RNA-to-cDNA kit (Life Technol-
ogies) as indicated in the manufacturer’s instructions. Each
reaction was done in 20 l with 400 ng of RNA. Quantitative
determination of mRNA of the five uncoupling protein iso-
forms were performed with the fast real time PCR system
7900HT (Applied Biosystems, Rotkreuz, Switzerland). The fol-
lowing primers were used: mUCP1Fo519, 5-CGA CTC AGT
CCA AGAGTA CTT CTC TTC; mUCP1Re591, 5-TCC CCT
GTT GAT GTG GTC AA; mUCP2Fo992, 5-TCC CCT GTT
GATGTGGTCAA;mUCP2Re1062, 5-CAGTGACCTGCG
CTG TGG TA; mUCP3Fo78, 5-CCT ACG ACA TCA TCA
AGG AGA AGT T; mUCP3Re863, 5-TCC AAA GGC AGA
GAC AAA GTG A; mUCP4Fo13, 5-GAA TGC CTA TCG
CCG AGG A; mUCP4Re85, 5-AGT AGG AAC TTG CTC
GTC CGG; mUCP5Fo602, 5-TCC CAA CTG CTC AGC
GTG; mUCP5Re673, 5-GGT GCT TCT TGG TAA TA TCA
TAA ACG; mActinFo31, 5-GCT TCT TTG CAG CTC CTT
CGT;mActinRe94, 5-ATATCGTCATCCATGGCGAAC;
mTBPFo271, 5-ACC TTA TGC TCA GGG CTT GGC C; and
mTBPRe359, 5-GTC CTG TGC CGT AAG GCA TCA TTG.
All primers pairs were designed to overlap exon-exon junc-
tion to avoid contamination signal from eventual genomic
DNA. Genes for -actin and TATA box binding protein were
used as reference genes for the normalization. The Power SYBR
Green (AppliedBiosystems)was used as aTaqpolymerasemas-
ter mix. All samples were analyzed in triplicate. The results
were analyzed with the SDS2.3 software (Applied Biosystems).
To compare the expression difference,we first convert the cycle
threshold (CT) in copies number by applying the rule thatCT
10 is equivalent to 1E11 copies and CT 37.34 is equivalent to
625 copies. We then calculate a normalization value for each
sample of the reference genes by dividing each absolute value by
the geomean calculated for each reference gene. We obtain a
normalization factor for each gene used as calibrator (-actin,
TATA box binding protein). To obtain a calibrator number, we
calculated the geomean from these reference numbers. We
divided each absolute value obtained for the different samples
by this final calibrator number. The result is a normalized value
of gene expression for the different UCPs that keep the differ-
ences of expression between the various UCPs intact.
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Lentiviral DNA Constructs—mRNA for UCP4 and UCP5
were isolated from brain of OF1 mice. Reverse transcription
was prepared by using 200 ng of extracted mRNA in 50 l of
total RT. Specific cDNA was obtained by PCR with the follow-
ing primers: mUCP4FoEcoRI, 5-GAA TTC TGC TGA ATG
CCT ATC GCC; mUCP4ReSphI, 5-GCA TGC ATG GGC
TGACTCCACTC;mUCP5FoEcoRI, 5-GAATTCGTGAAT
GGGTATCTTTCC; andmUCP5ReXhoI, 5-CTCGAGGAT
CTG AAG CCT CTT GA.
PCR products were cloned in the pGEMT vector (Promega),
and UCPs genes were isolated by restriction digestion with
EcoRI and SphI for UCP4 and with EcoRI and XhoI for UCP5
and were cloned in the pIRES-hrGFP-2a vector (Stratagene).
The gene of interest is thus fused to three contiguous copies of
the HA epitope (AGC GTA GTC AGG TAC ATC GTA AGG
GTA AGC GTA ATC CGG AAC GTC GTA CGG ATA CGC
GTAGTC TGGAACGTCATA TGGGTA). The next step in
the lentiviral construction is the use of the Gateway System.
UCP-HA genes were amplified from the pIRES-hrGFP-2a vec-
tor by PCR using the following primers: mUCP4FoTopo,
5-CAC CAT GGG ACC TAT CGC CGA GGA GGA GAA;
mUCP5FoTopo, 5-CAC CAT GGG TAT CTT TCC CGG
AAT AAT CC; and mUCPsReTopo, 5-ATC TTG TTA AGC
GTA GTC AGG TAC ATC GTA AG.
PCRs were performed with a proof reading polymerase (Pfu
polymerase), and the blunt end PCR products were directly
cloned in the pENTR/D-TOPO using the pENTR/D-TOPO
cloning kit (Invitrogen). Transfer into the lentiviral vector
SIN-PGK-CassRFA-WHV (kindly provided by Dr. H. Hirling,
Lausanne, Switzerland) was performed with the Gateway LR
Clonase II enzyme mix (Invitrogen) according to the manufa-
cturer’s protocol. The lentiviral vectors sequences for silencing
UCP4 and UCP5 were purchased from Open Biosystems (ref-
erence number for UCP4, RMM3981-97057374, reference
number for UCP5, RMM3981-97057464).
Lentivirus Production—HEK 293T cells were transfected
with 13 g of pCMV8.92, 3 g of pRSV-ReV, 3.75 g of
pMD2G, and 13 g of the vector SIN-PGK-WHV containing
the transgene per Petri dish with the calcium phosphate
method and maintained at 37 °C in a humidified atmosphere
containing 5% CO2 and 95% air. Medium was replaced 6–8 h
later. Medium containing lentiviruses were collected 3 days
after transfection, filtered at 0.45 m (Stericup SCHVU01RE;
Millipore), and spun at 19000 rpm for 90 min at 4 °C in an
ultracentrifuge using SW32Ti rotors (BD Biosciences). The
supernatants were removed, and each pellet containing viruses
was suspended in PBS, 0.5% BSA and frozen at 80 °C. Viral
titration was determined using the HIV-1 P24 ELISA kit (Zep-
tometrix Corporation, Buffalo, NY) as indicated in themanufa-
cturer’s instructions. For UCP overexpression, astrocytes were
infected from days 3 to 5 in vitro with a final concentration of
400 ng of p24 per 35-mm Petri dish. As a control, we infected
astrocytes with a lentivirus coding for GFP. The UCP expres-
sion was similar to noninfected astrocytes (data not shown),
suggesting that the infection itself had no effect on UCP gene
expression. For gene silencing, astrocytes were infected at a
final concentration of 100 ng of p24 per 35-mm Petri dish. The
mature antisense coded by the shUCP4 virus was AAT ATT
GGGTATCCAGCCTGC.Themature antisense coded by the
shUCP5 virus was ATT TCT TTG AAA CGA ACA TCG. As a
control of gene silencing, we infected astrocytes with a lentivi-
rus made with a vector containing no sequence.
Western Blots—When astrocytes reached confluency at day
21 in vitro, 35-mm Petri dishes of infected cells were placed on
ice and rinsed with ice-cold PBS. Cells were homogenized and
proteins were extracted with 200 l/dish of lysis buffer (30 mM
HEPES, 210 mM sucrose, 40 mM NaCl, 2 mM EDTA, 1% SDS,
and a mixture of protease inhibitors (Complete 11257000;
Roche). Each condition was made in duplicate, and two dishes
were mixed. Protein samples were sonicated and frozen at
80 °C. 10 l of each samples were mixed to 10 l of 2 load-
ing buffer (100mMTris-Cl, pH 6.8, 200mMDTT, 4% SDS, 0.1%
bromphenol blue, 10% glycerol) and heated at 100 °C for 4
min before loading onto an Invitrogen NuPage 10% gel
(NP0301BOX). When proteins were loaded after mitochon-
drial isolation following the mitochondria isolation kit
(MITOISO1; Sigma-Aldrich) protocol, 2.5 g of protein were
loaded. Gel was run at 100 volts at 4 °C. After running, proteins
were transferred on nitrocellulose membranes (84261514;
Whatman) in a Tris-glycine transfer buffer (0.4 M glycine,
0.25 M Tris-base, pH 6.8, 20% methanol). Transfers were done
by application of 75 volts for 80 min at 4 °C. Membranes were
incubated for 1 h in the Odyssey blocking buffer (927-40000;
LI-COR) at room temperature and then incubated overnight at
4 °C with primary antibodies polyclonal anti-HA (1:4000)
(AB9110; Abcam), monoclonal anti- actin (1:5000) (A5441;
Sigma-Aldrich), or monoclonal anti-cytochrome c oxidase
(1:1000) (MS407; Mitosciences) diluted in the same blocking
buffer. After several washes in PBS, secondary antibodies anti-
mouse IgG IRDye 800 (1:5000) (610-132-121; Bioconcept) and
anti-rabbit IgGAlexafluor 680 (1:5000) (Juro, Lucerne, Switzer-
land) were applied for 2 h at room temperature and protected
from light. After washing, membranes were scanned with the
ODYSSEY Infrared Imaging System (LI-COR Biosciences).
Immunocytochemistry—Astrocytes grown on 20-mm cover-
slips and infected with UCP lentiviral constructs were carefully
rinsed with PBS before being fixed in cold paraformaldehyde
4% for 15 min at room temperature. Treatment with PBS, 0.1%
Triton for 15minwas performed to permeabilize the cell mem-
branes. After three PBS washes, fixed cells were then treated
with casein (0.5% in PBS) for 1 h at room temperature to block
nonspecific sites. Fixed cultures were then incubated overnight
at 4 °C in the presence of the primary antibodies polyclonal
anti-HA (1:500) (AB9110; Abcam), polyclonal GFAP (1:500)
(Z0334; Dako), or monoclonal anti-cytochrome c oxidase
(1:500) (MS407; Mitosciences). After three repeated washes in
PBS, cells were incubated in the secondary antibodies goat
anti-rabbit Alexa 488 (1:200) (A11008; Invitrogen) and goat
anti-mouse Alexa 594 (1:200) (A11005; Invitrogen) for 2 h at
room temperature in the dark. After rinsing, coverslips were
mounted in a solution containing 50% glycerol and DABCO
(D2522; Sigma-Aldrich) to reduce photobleaching. Z-stack
acquisitions were done using a confocal microscope ZEISS
LSM710. The images underwent deconvolution usingHuygens
Remote Manager v1.2.2 and were then analyzed using the
Imaris Software (BitplaneCorp.). Co-localization betweenUCP
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andmitochondria was calculated with theManders’ coefficient
which is the part of the intensity in each channel that coincides
with a number of intensity in the other channel (with 0 indicat-
ing no co-localization and 1 indicating perfect co-localization).
Glucose Uptake Assay—Glucose uptake was measured as
previously described (23). The effect of glutamate on astrocytic
glucose uptake wasmeasured in parallel in other Petri dishes by
adding glutamate 200 M in the medium containing [3H]2-de-
oxyglucose for 20 min of incubation. Other Petri dishes were
used tomeasure the portion of glucose uptake that is not linked
to glucose transporter by addition of the glucose transporter
inhibitor cytochalasin B (C6762; Sigma-Aldrich) 25 M during
20 min of incubation. The fraction of glucose transported is
calculated by subtracting the fraction of glucose uptake that is
not inhibited by the cytochalasin B. Glucose uptake was nor-
malized to the protein content.
Glycogen Content—Glycogen content was measured enzy-
matically as previously described (22). In brief, astrocytes
grownon 35-mmPetri dishes and previously infectedwithUCP
lentiviral constructs werewashed three timeswith ice-cold PBS
and lysed by sonication in HCl 30 mM. Two aliquots of 100 l
were sampled. 300l of 0.1 M acetate buffer, pH4.65, was added
to the first aliquot, whereas the same buffer containing 1% amy-
loglucosidase (10 mg/ml) was added to the other one. After
incubation at room temperature for 30 min, 2 ml of 0.1 M Tris-
HCl buffer, pH 8.1, containing 3.3mMMgCl2, 0.33mMATP, 38
M NADP, 4 g/ml hexokinase, and 2 g/ml glucose-6-phos-
phate dehydrogenase were added, and the mixture was incu-
bated at room temperature for 30min. Fluorescence associated
with the formation of NADPHwas read on a fluorometer using
excitation wavelength at 340 nm and emission wavelength at
450 nm. Glycogen was normalized to protein content and was
expressed as glycosyl units originating from glycogen. The
results are expressed as percentages of control values.
Mitochondrial Potential Measurement—Astrocytes grown
on a multiplate of 48 wells and previously infected with UCP
lentiviral constructs were rinsed carefully and incubated 1 h in
phenol red-free DMEM (D5030; Sigma) supplemented with 2
mM glucose and 44mMNaHCO3. After rinsing, cells were incu-
bated in the same medium containing 5 g/ml JC-1 dye
(T-3168; Invitrogen) for 30 min at 37 °C in an atmosphere con-
taining 5% CO2 and 95% air and protected from light. The JC-1
dye exhibits potential dependent accumulation in mitochon-
dria, indicated by a fluorescence emission shift from green to
red (24, 25). At low potential, monomers are formed that dis-
play green fluorescence, whereas at higher potential, JC-1
aggregates and exhibits a red fluorescence. Cells were carefully
rinsed with PBS to remove any extracellular dye, and fluores-
cence was directly detected on the multiplate using a fluoro-
meter (Safir 2; Tecan). The wavelengths used are emission 497/
excitation 594 for the red fluorescence and emission 497/
excitation 524 for the green fluorescence. The mitochondrial
potential was estimated by calculating the ratio of green to red
fluorescence. The results are expressed as percentages of con-
trol values.
ATP/ADP Ratio—ATP content was measured enzymatically
with the luciferase. In the presence of ATP, Mg2, and oxygen,
luciferin is oxygenated by luciferase into oxyluciferin. This
reaction emits light that is proportional to the amount of ATP.
ATP was determined with the CellTiter-Glo Luminescent cell
viability assay (Promega) with some modifications. Astrocytes
grown on multiplate of 48 wells and previously infected were
rinsed and incubated 1 h at 37 °C in an atmosphere containing
5% CO2 and 95% air in DMEM (D5030; Sigma-Aldrich) con-
taining 44 mM NaHCO3 and 2 mM glucose. At the end of the
incubation, medium was removed, and 200 l of Tricine buffer
solution (40mMTricine, 3mMEDTA, 85mMNaCl, 3.6mMKCl,
100mMNaF, and 0.1% saponin (84510; Sigma-Aldrich), pH 7.4)
was put in each well. Cells were lysed by saponin effect and by
pipetting. The saponin is a “soft” soap that breaks cell mem-
branes but preserves the enzymatic reaction. Each sample was
separated in two: one part for ATP measure and the other part
for ATP  ADP measure. 90-l aliquots were distributed in a
black-walled 96-well type microplates (PerkinElmer Life Sci-
ences). For the ATP ADPmeasure, 10 l of converting solu-
tion (100 mM Tricine, 100 mMMgSO4, 25 mM KCl, 1 mM phos-
phoenolpyruvate, and 100 units/ml pyruvate kinase), pH 7.75,
was added in each well, whereas the same solution without
phosphoenolpyruvate and pyruvate kinase was added to the
samples for ATP measure. An incubation of 5 min at room
temperature was performed before adding 10l ofMgCl2 solu-
tion (4 mM Tricine and 100 mMMgCl2). Finally, 100 l of Cell-
Titer-Glo reagent (G7571; Promega) was added, and lumines-
cence was immediately detected with a luminometer (Safire 2;
Tecan). Luminescence was measured in a kinetic way deter-
mined by 20 readings at intervals of 1 min. Luminescence read
at the plateau were taken to calculate the ATP/ADP ratio. ADP
values were calculated by subtracting ATP values from ATP
ADP values. The results are expressed as percentages of control
values.
Hydrogen Peroxide Quantification—H2O2 accumulated in
the medium and was detected enzymatically with Amplex red
(26, 27). Oxidation of Amplex red is catalyzed by the horserad-
ish peroxidase in the presence of H2O2 into highly fluorescent
resorufin. When reaching confluency, astrocytes grown on
multiplates of 24 wells and previously infected with UCP lenti-
viral constructswere carefully rinsed before being incubated 4h
in phenol red free Neurobasal medium supplemented with
GlutaMAX and B27 without antioxidant (B27 minus AO) and
containing 10 M Amplex red (A12222; Invitrogen) and 1
unit/ml horseradish peroxidase (type II, P8250; Sigma-Al-
drich). At the end of the incubation, 100 l were loaded on a
black-walled 96-well plate (PerkinElmer Life Sciences), and flu-
orescence was detected using wavelengths at 545 nm for exci-
tation and 590 nm for emission. The results are expressed as
percentages of control values.
NAD/NADH Cycling Assay—NADH and NAD were
measured enzymatically as previously described (28) with some
modifications. NAD is reduced by alcohol dehydrogenase in
the presence of ethanol. NAD is renewed by the reduction of
phenazine ethosulfate, whose oxidized form is restored by the
reduction of MTT. Reduced MTT is visualized by absorbance
at 570 nm. Infected astrocytes grown on 35-mm Petri dish and
reaching confluency were incubated 24 h in phenol red-free
Neurobasal medium without glucose (0050128DJ; Invitrogen)
supplemented with 5 mM glucose, B27, and GlutaMAX. The
UCP4 Regulates Intramitochondrial pH
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cells were then put on ice and washed three times with ice-cold
PBS. Cells were recovered in 600 l of carbonate-bicarbonate
(20 mM to 100 mM) buffer, pH 10, containing 10 mM nicotina-
mide (72340; Sigma-Aldrich) and were directly frozen to dis-
rupt cellmembrane.Once thawed, the sampleswere kept on ice
and separated in two parts: one for the dosage of NADH 
NAD and the other for NADH only. Samples for NADH
detectionwere heated at 60 °C for 30min to destroyNAD and
were kept on ice. 50l of each sampleswere loaded on a 96-well
microplate, and the reaction was initiated by addition of 150 l
of reaction mix composed of 133 mM Bicine (14871; Sigma-
Aldrich), 5.33 mM EDTA, 0.56 mM MTT (M5655; Sigma-
Aldrich), 2.21 mM phenazine ethosulfate (0210095601; MP
Biomedicals), 667 mM ethanol, and 40 units/ml alcohol dehy-
drogenase (A3263; Sigma-Aldrich). Reduction ofMTTwas fol-
lowed by measuring absorbance at 570-mm 30 times at inter-
vals of 30 s. NAD values were calculated by subtracting
NADH from NADH  NAD values. Concentrations were
determined from a standard curve from 0.1 to 2 M NADH
(10107735001; Roche) andwere normalized to the protein con-
tent. the results are expressed as percentages of control
conditions.
CO2 Production Assay—CO2 production was measured by
incorporation of radioactive labeled glucose as previously
described (29). This technique enabled us to distinguish the
quantity of CO2 produced by glucose metabolism via the TCA
cycle between those produced by the pentose phosphate path-
way. D-[1-14C]Glucose produces 14CO2 via the two pathways,
whereas 14CO2 produced by D-[6-14C]glucose is exclusively
provided by the TCA cycle. CO2 produced specifically by the
TCA cycle is determined by metabolization of D-[6-14C]glu-
cose, whereas use of D-[1-14C]glucose gives the total amount of
CO2 formed.When reaching confluency, medium of astrocytes
growing on 35-mm Petri dishes was changed for DMEM
(D5030; Sigma-Aldrich) containing 2.5 mM glucose, 7.5 mM
NaHCO3, 5 mM HEPES, and 10 ml/liter antibiotic/antimycotic
solution, and cells were incubated 2 h at 37 °C in an atmosphere
containing 5%CO2 and 95% air. Themediumwas then replaced
by 1 ml of the same medium supplemented with 2.3 Ci/ml
D-[1-14C] (CFA349; Amersham Biosciences) glucose or D-[6-
14C]glucose (CFA351; Amersham Biosciences), and culture
dishes were placed in sealed glass containers and incubated for
2 h at 37 °C. 0.2 M HCl was injected in dishes containing the
respiring cells to stop the reaction, and radioactive 14CO2 was
captured by addition of 1 ml of Carbo-Sorb (PerkinElmer Life
Sciences) against the walls of the container. These were kept
aside 1 h for equilibration, and two aliquots of 400 l of Carbo-
Sorb were taken for radioactivity assay by liquid scintillation
counting (Permafluor E; PerkinElmer Life Sciences). The val-
ues were normalized to the protein content, and the results are
expressed as percentages of control values.
Oxygen Consumption Rate—The oxygen consumption rate
(OCR) was assessed using a noninvasive extracellular flux ana-
lyzer (XF24; Seahorse Biosciences, North Billerica, MA). It is
composed of two calibrated optical sensors that directly mea-
sure the oxygen consumption rate in a 7-l microchamberwith
limited diffusion. The depletion of oxygen in the medium is
then measured several times during a defined period. Injector
ports surrounding the sensor of each well can be used to auto-
matically deliver drugs during the experiment. The cells were
plated in XF24 wells (XF24 FluxPaks, 100850-001; Bucher,
Basel, Switzerland) of 0.38 cm2 area per well and incubated for
1 h in a non-CO2 incubator with unbuffered medium before
loaded in the XF24 Analyzer. For astrocytes, the medium was
composed of DMEM (D5030; Sigma-Aldrich) supplemented
with 32 mM NaCl, 15 mg/liter Phenol red, 10 mM 2-deoxyglu-
cose, 5 mM glucose, and 5 mM pyruvate. For neuronal cultures,
medium was composed of DMEM supplemented with 32 mM
NaCl, 15 mg/liter Phenol red, and 0.5 mM glucose. During the
measure, 200 M glutamate was first added in astrocytes cul-
ture. In neurons, glucose and/or lactate were injected at ener-
getically equivalent concentrations as indicated. In all cases,
later injection of 5Moligomycin (75352; Sigma-Aldrich) and 2
M carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone
(C2920; Sigma-Aldrich) provided estimation of the success of
the experiment. Effect of glutamate was normalized to the basal
OCR, as well as the effect of glucose and/or lactate in neurons.
The results are expressed as percentages of control values.
Mitochondrial Matrix pH—Two-week-old astrocytes were
placed in 2 ml of antibiotic-free and serum-free DMEM with
FuGENE (Roche) and DNA encoding for genetically encoded
pH indicator MitoSypHer (30). Quantities of DNA/FuGENE
were 2 g of DNA/12 l of FuGENE for MitoSypHer and 4 g
of DNA/8 l of FuGENE for MIMS-EYFP. After 4 h, the
medium was changed with DMEM plus 10% serum, and the
cells were used 2–3 days after transfection for pure astrocyte
culture and 14 days for mixed neuron-astrocyte cultures. Mito-
chondrialmatrix pHwasmeasured by fluorescencemicroscopy
as previously described (20). Briefly, cells were placed in a ther-
mostatted chamber designed for rapid exchange of perfusion
solutions (31) and superfused at 35 °C. Experimental solution
contained 160 mM NaCl, 5.4 mM KCl, 20 mM HEPES, 1.3 mM
CaCl2, 0.8 mM MgSO4, 0.78 mM NaH2PO4, 5 mM glucose (pH
7.4) and was bubbled with air. MitoSypHer fluorescence was
sequentially excited at 490 and 420 nm and detected at 	515
nm. At the end of each experiment, in situ calibration was per-
formed by permeabilization of cells with 10Mmonensin and 3
M gramicidin and superfused with a series of calibration solu-
tions of given pH values (pH 5.9, 7.0 7.5, and 8.0). Calibration
solutions contained 20 mM NaCl, 125 mM KCl, 0.5 mM MgCl2,
0.2 mM EGTA, 20 mM HEPES and bubbled with air.
Lactate Release Assay—Lactate released by astrocytes previ-
ously infected with UCP lentiviral constructs was determined
with an enzymatic method, first described by Rosenberg and
Rush (32)with somemodifications. Lactate dehydrogenase oxi-
dizes lactate into pyruvate in the presence ofNAD. The result-
ing NADH is measured by fluorometry. 24 h after co-culture
initiation, 10 l of mediumwas taken andmixed with 190 l of
medium. This was mixed with 1 ml of 0.2 M glycine-semicarba-
zide, pH 10 buffer containing 2mg/mlNAD and 13.75 units/ml
lactate dehydrogenase andwas incubated at 40 °C for 1 h. 200l
of this reactionwas transferred into a black-walled 96-well plate
(PerkinElmer Life Sciences). The formation of NADH was
measured by fluorescence (Safire 2; Tecan) using excitation
wavelength at 340 nm and emission wavelength at 450 nm.
Absolute values were determined from a standard curve, and
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lactate release in the medium was normalized to the DNA
quantity in each Petri dish using the PicoGreen method. For
this normalization, cells were incubated for 5 min in PBS con-
taining PicoGreen solution (P7589; Invitrogen) diluted 1:200.
After washing, fluorescence was measured using excitation
wavelength at 480 nm and emission wavelength at 520 nm. The
results are expressed as percentages of control values.
Viability Test: CalceinAssay—48h after co-culture initiation,
coverslips with neurons were transferred to new wells contain-
ing Neurobasal medium supplemented with GlutaMAX, B27
without antioxidant (B27minus AO), and 1g/ml calcein-AM.
Neurons were carefully rinsed, and calcein fluorescence was
measured directly in the multiwell plate with a fluorescence
reader (Safire 2; Tecan) with excitation wavelength of 490 nm
and emission of 515 nm. The calcein fluorescence was normal-
ized to the cell quantity in each well by adding the nucleus
marker DAPI (D9542; Sigma-Aldrich). Neurons were incu-
bated for 10 min in PBS containing DAPI 7 g/ml, and after
rinsing, DAPI fluorescence was measured using excitation
wavelength at 360 nm and emission at 461 nm. The results are
expressed as percentages of control values.
Viability Test:MTTReductionAssay—Viability of neurons in
co-culture were measured with the MTT (M5655; Sigma-
Aldrich) reduction assay (33). 48 h after co-culture initiation,
MTT was directly put into the co-culture medium to a final
concentration of 0.2 mg/ml, and cells were incubated 30 min
at 37 °C in an atmosphere containing 5% CO2 and 95% air. At
the end of the incubation, neuronal coverslips were trans-
ferred to new wells containing 500 l of DMSO to stop the
reaction of dehydrogenases. The amount of reduced MTT
(formazan) solubilized in DMSO was then determined spec-
trophotometrically using absorbance at 560 nm (Safire 2;
Tecan). The values were normalized to the DNA quantity in
each well. For this normalization, the cells were incubated
for 5 min in PBS containing PicoGreen solution (P7589;
Invitrogen) diluted 1:200. After washing, fluorescence was
measured using excitation wavelength at 480 nm and emis-
sion wavelength at 520 nm. The results are expressed as per-
centages of control values.
Mitochondrial Mass Determination—To determine mito-
chondrial mass in astrocytes or neurons, we used Mitotracker
Red FM (M-22425; Invitrogen). Cells in culture were rinsed
with prewarm PBS before incubation in DMEM (D5030; Sig-
ma-Aldrich) supplemented with 2 mM glucose, 44 mM
NaHCO3, and 20 nM Mitotracker Red 580 (M-22425; Invitro-
gen) for 20 min at 37 °C. The cells were rinsed with PBS, and
fluorescence was measured using excitation wavelength at 581
nm and emission wavelength at 664 nm. The values were then
normalized to the DNA quantity in each well using the
PicoGreen as described above for the MTT measurement.
Statistics—All results are presented as the means
 S.E. The
data were analyzed for statistical significance against respective
controls by analyze of variance with multiple comparisons
using Dunnett’s post hoc test. *, **, and *** refer to p values
0.05, 0.01, and 0.001, respectively. The software used was
Instat 3.0 software (GraphPad, San Diego, CA).
RESULTS
Mitochondrial Localization of Overexpressed UCPs in Astro-
cytes—Expression of various UCPs in the brain has been previ-
ously reported (8, 34). The results presented in Table 1 summa-
rize the expression levels for each UCPs isoform in astrocyte
and in neuron mouse primary cultures. UCP2, UCP4, and
UCP5 are the main UCP isoforms and are expressed both in
astrocytes and neurons.
Overexpression of the various isoforms of uncoupling pro-
tein in primary cultures of astrocytes through viral transfection
results in an increased expression of the corresponding UCP
isoform as determined by RT-PCR. The increase ranged from a
250-fold increase in mRNA for UCP2, UCP4, and UCP5 to
30,000-fold for UCP1 and UCP3 (one should note that the
expression levels of these two latter isoforms were extremely
low before transfection). Using silencing constructs for UCP4
or UCP5 (see “Experimental Procedures”), we observed a
reduction in the corresponding UCPs mRNAs (data not
shown).
We also analyzed the expression and the subcellular localiza-
tion of overexpressed uncoupling proteins byWestern blotting
and immunohistochemistry. For increased specificity, we used
an hemagglutinin epitope (HA tag) (see “Experimental Proce-
dures”) fused to UCP sequences that allows us to determine the
expression of each overexpressed isoform.As seen in Fig. 1A, all
isoforms are present in astrocytes infected with the corre-
sponding UCP construct, detected by a band close to 32 kDa.
For the UCP5 protein, two bands were observed in some blots,
most likely resulting from alternative splicing (9).
UCP4 and UCP5 overexpression was also determined in
mitochondrial preparations. Mitochondrial fraction was sepa-
rated from cytosolic fraction and run on a polyacrylamide gel.
Antibody against cytochrome oxidase was used as a marker of
the mitochondrial fraction. Uncoupling proteins 4 and 5 were
highly enriched in the purifiedmitochondrial fraction (Fig. 1B).
Mitochondrial localization of the overexpressed uncoupling
proteins was also confirmed by immunohistochemistry in
astrocytes. Primary antibodies directed against the HA tag and
the mitochondrial cytochrome oxidase were used for co-local-
ization analysis. The UCP4-HA (Fig. 1C) is revealed in green,
whereas cytochrome oxidase is revealed in red, and co-localiza-
tion appears in white. The results in Fig. 1C showed that
UCP4-HA co-localized with the cytochrome oxidase, suggest-
ing that the overexpressed uncoupling protein was targeted to
the mitochondria.
We tested the viability of the lentivirus-infected astrocytes
using the calcein test and found that it did not affect cell survival
TABLE 1
Quantitative PCR levels of the different UCPs isoforms in astrocytes
and neurons mouse primary cultures
To assess real differences level of mRNA for the various UCPs isoforms, we convert
quantitative PCR data in copy number. To evaluate the differences between the
different UCP isoforms, we have arbitrary set the UCP4 copy number to 100. The
other UCPs isoforms are shown as percentages compared with astrocyte UCP4
expression level. This representation highlights the differences of eachUCP isoform
between astrocytes and neurons expression levels.
UCP1 UCP2 UCP3 UCP4 UCP5
Astrocytes 0.33
 0.02 183
 3 0.08
 0.02 100
 2 291
 12
Neurons 1.72
 0.27 119
 45 0.06
 0.02 321
 35 478
 32
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(control, 99.7 
 7.4; UCP4over, 92.9 
 7.6; UCP5over, 92.2 

9.3, expressed as percentage of viable cells; n  five indepen-
dent cells cultured in quadruplicate); there were no statistically
significant differences between group means. We also found
that UCP overexpression or UCP silencing did not significantly
change the mitochondrial mass using a Mitotracker probe not
sensitive to the redox state of themitochondria (control, 99.2

0.2; UCP4over expression, 107.3 
 2.8; UCP5over expression,
117.2 
 12.0; UCP4 silencing, 95.6 
 3.6; UCP5 silencing,
93.5 
 4.1; expressed as percentages of control; (n  seven
independent cells cultures in quadruplicate); there were no sta-
tistically significant differences between group means. To
assess the UCP4 and UCP5 reduction in astrocytes infected
with either the shUCP4 or shUCP5 virus (Fig. 2C), we quanti-
fied the mRNA level of both UCPs isoforms. We measured a
66% reduction of UCP4 mRNA in astrocytes expressing the
shUCP4 and a 94% reduction of UCP5 mRNA in astrocytes
expressing the shUCP5. Importantly, the shRNA treatment had
an effect only on the targeted UCP expression and not on the
expression of the other UCP isoforms.
Effect of Uncoupling Proteins on Astrocytic Glucose Metab-
olism—As previously described, glutamate released in the syn-
aptic cleft is rapidly cleared by an active uptake into astrocytes.
One glutamate is co-transported with three Na. Intracellular
Na homeostasis is re-established by the Na/K-ATPase,
which requires ATP provided mainly by glycolysis. The result-
ing lactate is released by astrocytes in extracellular space and
contributes to the energetic balance of activated neurons in a
mechanism known as the astrocyte-neuron lactate shuttle (35,
36). Because mitochondria play a key role in energy metabo-
lism, we investigated the consequences of modifying UCP
expression in astrocytes on the metabolic coupling between
astrocytes and neurons. Glucose uptake, lactate release, and
glycogen content were measured as an index of astrocytic glu-
cose metabolism. Glutamate promotes glucose uptake into
astrocytes (21). Overexpression of different UCP isoforms did
not affect glucose uptake either under basal conditions or fol-
lowing glutamate stimulation (Fig. 2A) as revealed by the [3H]2-
deoxyglucose experiments. Similarly, UCP4 or UCP5 silencing
was without effect on basal glucose uptake. However, UCP4
silencing significantly reduced glutamate-stimulated glucose
uptake by 34
 5.4% comparedwith control astrocytes (Fig. 2A,
arrow).
It has been shown that during neuronal activation, glutamate
exposure increased lactate release from astrocytes (21). Lactate
release was measured at the end of the 20-min glucose uptake
experiments in control and UCPs overexpressing astrocytes
stimulated or not with glutamate. Overexpression of uncou-
pling proteins did notmodify the basal or glutamate-stimulated
astrocytic lactate release. In contrast, overexpression of UCP4
or 5 reduced the glycogen content of astrocytes (Fig. 2B), sug-
gesting that astrocytes with artificially modified metabolism
can metabolically adapt drawing on their glycogen stocks.
UCP4 and UCP5 Reduced the Mitochondrial Function in
Astrocytes—The uncoupling proteins derive their name from
the uncoupling activity of UCP1 in brown adipose tissue cells.
UCP1 dissipates their proton gradient by translocating H
across the mitochondrial membrane, thereby producing heat
instead of ATP. There is no clear evidence that other UCPs
decrease the mitochondrial proton gradient. We have tested
the hypothetical uncoupling activity ofUCP2,UCP4, andUCP5
in astrocytes by measuring the mitochondrial membrane
potential and the ATP/ADP ratio. We observed that the mito-
chondrial potential is reduced in the presence of overexpressed
UCP4 or UCP5 (Fig. 3A, black columns), but not when UCP2 is
overexpressed. AstrocyticUCP4 reducedmitochondrial poten-
tial by 6% compared with control and UCP5 reduced the mito-
chondrial potential of astrocytes by 13%. Surprisingly, UCP1
FIGURE 1.Mitochondrial localization of overexpressed UCPs in astrocytes. A, Western blot showing the expression of each HA-tagged isoform of UCPs. B,
localizationof overexpressedUCP.HA-taggedoverexpressedUCP4andUCP5werepresent in the total fraction andwerepurified in themitochondrial fraction.
C, immunohistochemistry showing the co-localization of UCP4-HA (green) and cytochrome oxidase (red). Thresholded Manders’s coefficient (green versus red
channel) was 0.93, indicating a very high degree of correlation. Ctrl, control; Cyt., cytosolic fraction;Mito., mitochondrial fraction; Tot., total fraction.
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overexpression had no effect on the mitochondrial potential of
astrocytes (not shown). This suggests that UCP activity is tis-
sue-specific. Silencing of UCP4 and UCP5 had the opposite
effect to overexpression, resulting in an increase in the mito-
chondrial potential by 10% (Fig. 3A, gray columns). These
results confirm the implication of UCP4 and UCP5 in mito-
chondrial potential in astrocytes.
In mitochondria, ATP production is closely linked to the
proton gradient across the inner mitochondrial membrane.
Because ATP synthase requires the protonmotive force to pro-
duce ATP, it is expected that a reduction in mitochondrial
potential leads to a reduction in ATP formation. Accordingly,
overexpression of UCP4 or UCP5 significantly decreases the
ATP/ADP ratio in astrocytes by 12–14% (Fig. 3B, black col-
umns). These results suggested a leak of protons from the
intramitochondrial matrix via uncoupling proteins, which led
to a decreased activity of the FoF1-ATP synthase. Silencing
yielded the reverse effect for bothUCP4 and 5, i.e. increased the
ATP/ADP ratio by 20%, supporting this conclusion (Fig. 3B,
gray columns).
A possible role for the uncoupling protein described in the
literature (for review, see Ref. 37) is the reduction of ROS pro-
duction. Indeed, a mild uncoupling has been shown to have a
moderating effect on oxidative stress.We tested this protective
effect for the two brain isoforms of uncoupling proteins in
astrocytes. We chose to measure superoxide anion production
as an index of ROS production. However, because of its very
short half-life, we quantified H2O2 release as an alternative.
Overexpression of UCP4 or UCP5 significantly reduced H2O2
release into the medium of astrocyte cultures by 9–11% com-
pared with control cells (Fig. 3C, black columns). In contrast,
silencing ofUCP4 andUCP5 resulted in enhancedH2O2 release
by 127 and 133%, respectively, of control cells (Fig. 3C, gray
columns).
UCP4 Enhanced TCACycle Activity in Astrocytes—The TCA
cycle plays a key role in energy production: its activity can be
monitored by determining the NAD/NADH ratio and CO2
production. The NAD/NADH ratio is an important compo-
nent of the redox state of a cell; it is controlled by the activity of
several enzymes, including glyceraldehyde-3-phosphate dehy-
FIGURE 2. Effects of UCP2, UCP4, andUCP5 on astrocytic glucosemetabolism and the effect of silencingwith shUCP4,5 on respectivemRNA levels. A,
glucoseuptakebefore (blackbars) andafter (graybars) glutamateexposure. Thepresenceofglutamate increasedglucoseuptakeby45%.UCPsoverexpression
had no effect on glutamate-stimulated glucose uptake. The results are means of triplicates of eight independent experiments. Silencing of UCP4 reduced
glutamate-stimulated glucose uptake compared with control conditions. We have subtracted from each value represented by an histogram the value of
passive glucose uptake obtained when glucose transporter are blocked with cytochalasin B. B, overexpression of UCP4 and UCP5 reduced glycogen content
compared with control conditions. The results are means of triplicates of six independent experiments. C, mRNA level of UCP4 and UCP5 genes in astrocytes
expressing either the shUCP4 or shUCP5. Ctrl, control; 2-DG, 2-deoxyglucose; glut, glutamate.
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drogenase and pyruvate dehydrogenase. The TCA cycle is an
important source of NADH providing reducing equivalents to
the respiratory chain. Astrocytes overexpressing UCP4 showed
a 33% reduction of the NAD/NADH ratio compared with
control astrocytes (Fig. 4A, black columns). In contrast, UCP4
silencing increased the ratio by 148% of control levels (Fig. 4A,
gray columns), suggesting that the cell is in amore reduced state
in these conditions. Modulation of UCP5 expression was with-
out effect.
The decrease in the NAD/NADH ratio observed following
UCP4 overexpression could result both from an increase in the
TCA cycle activity and/or a reduced activity of the respiratory
chain. Because we found that oxidative phosphorylation was
decreased (mitochondrial potential and ATP/ADP ratio) fol-
lowingUCP4overexpression,wewanted to investigatewhether
the TCA cycle activity was reduced as well. To test this hypoth-
esis, we measured the CO2 production from glucose radioac-
tively labeled in C1 or C6 to differentiate CO2 production
caused by the TCA cycle from total CO2 produced. We
observed that CO2 production by the TCA cycle was increased
by 31% in the presence of overexpressed UCP4 (Fig. 4B). Over-
expression of UCP5 had no significant effect.
Effects of UCP4 and UCP5 on Mitochondrial Respiration in
Astrocytes and Relation to Mitochondrial Acidification—Hav-
ing determined that UCP4 and UCP5 had an uncoupling activ-
ity by modifying the mitochondrial potential, the ATP/ADP
ratio, the H2O2 level, and NAD/NADH ratio and that UCP4
also affected the TCA cycle, we set out to determine the role of
UCPs in the final element of the electron transport chain,
namely the oxygen consumption. We analyzed the effect of
overexpressed or silenced UCP4 andUCP5 in astrocytes on the
OCR.Wemeasured the respiration profile of astrocytes for 2 h
including application of various compounds.We compared the
OCR of control astrocytes and astrocytes overexpressing or
silenced forUCP4 after 200Mglutamate stimulation (Fig. 5A).
We had previously shown that glutamate reduced the OCR in
astrocytes, a phenomenon dependent on the mitochondrial
matrix acidification (20). We could thus assume that if the
mitochondrial matrix acidification and the mitochondrial
potential reduction were linked and somehow controlled via an
UCP, we could expect that the astrocytic OCR decrease in the
presence of glutamatewould be enhancedwhen overexpressing
uncoupling proteins. We therefore measured the basal and
glutamate-stimulated OCR in astrocytes overexpressing or
silenced for UCP4 and UCP5. Glutamate application on astro-
cyte reduced OCR by 11% compared with basal level (Fig. 5A).
The OCR represented in Fig. 5B are showing that in nomal
medium astrocyte overexpressing UCP4 do have and higher
OCR, because the ATP/ADP ratio is reduced and mitochon-
drial potential is reduced. The silencing of UCP4 in these con-
ditions also shows a higher OCR than in control condition,
because we made these respiration measurements in the pres-
ence of deoxy-glucose, which blocks glycolysis. Abundance or
reduction of UCP4 in astrocyte modified the OCR response to
glutamate (Fig. 5C). Indeed, in the presence of glutamate, over-
expression of UCP4 decreased OCR by 16%; conversely, silenc-
ing of UCP4 decreased the OCR by only 2%.
As previously mentioned, the effects of glutamate on oxygen
consumption rate were shown to depend on the mitochondrial
matrix acidification (20). We tested the implication of uncou-
pling proteins on this acidification bymeasuring themitochon-
drial pH in astrocytes overexpressing UCP4 or UCP5, before
FIGURE 3. UCP4 and UCP5 reduced the mitochondrial function in astro-
cytes. A, mitochondrial electrical potential was reduced in the presence of
overexpressed UCP4 and UCP5 (black bars). Overexpression of UCP2 did not
modify the electrical potential of astrocytes. Control astrocytes are infected
with a virus containing theGFP sequence. The silencingof these two isoforms
increased the mitochondrial potential (gray bars), and control astrocytes are
infected with a virus targeting the GFP sequence. The results are means of
quadruplicates of at least 12 independent experiments. B, the ATP/ADP ratio
was reduced in the presence of overexpressed UCP4 and UCP5 (black bars);
opposite effectswere obtainedwith the silencing (gray bars). Overexpression
of UCP2 did not modify the ATP/ADP ratio of astrocytes. The results are
means of quadruplicate of at least 12 independent experiments. C, UCP4 and
UCP5 overexpression (black bars) reduced H2O2 level found in medium,
whereas silencing of UCP4 or UCP5 (gray bars) increased the release of H2O2.
The results are means of quadruplicates of at least 14 independent experi-
ments. Ctrl, control.
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and after stimulation by 200 M glutamate. Overexpression of
UCP4 reduced significantly the basal mitochondrial matrix pH
from pH 7.31 
 0.06 in control cells to pH 7.05 
 0.08 in
infected cells (Fig. 6). UCP4 silencing did not significantly affect
basal mitochondrial matrix pH, nor did UCP5 overexpression
or silencing. In control cells, glutamate application decreased
mitochondrial matrix to pH 6.64 
 0.1, whereas UCP4 silenc-
ing decreased pH to 6.88 
 0.05, therefore causing a milder
acidification. UCP5 did not significantlymodify the basal or the
glutamate-stimulated matrix pH neither in overexpression nor
in silencing. These results indicate that UCP4 is involved in the
glutamate-induced mitochondrial matrix acidification, which
is the likely cause of its effect on mitochondrial respiration.
UCP4-mediated Lactate Release from Astrocytes Improve
Neuronal Survival—It has already been demonstrated that
astrocyte-derived lactate is an important energy substrate for
neurons (12, 38–41). As an index of metabolic activity in neu-
rons, we measured the OCR of neurons exposed to the two
most relevant energy substrates, namely glucose and lactate. As
reported in Fig. 7A, the OCR is markedly increased in neurons
exposed to lactate (50 mM) alone compared with a mix of glu-
cose (12.5mM) and lactate (25mM) or to glucose alone (25mM).
All substrates or mixtures thereof were tested at equicaloric
final concentrations. Given the role of astrocytes in providing
lactate to neurons, we set out to study the possible involvement
of astrocytic uncoupling protein level of expression on lactate
production and in neuronal survival.
The release of lactate, accumulated for 24 h, was increased by
16% in astrocytes overexpressing UCP4 compared with control
astrocytes (Fig. 7B, black columns). UCP5 overexpression had
no significant effect on lactate release. Silencing of UCP4 or
UCP5 reduced lactate release to 88 
 4.2 and 80 
 2.6% of
control values, respectively (Fig. 7B, gray columns).
Because neurons exposed to lactate increased their respira-
tory rate (Fig. 7A), we measured the viability of neurons co-
cultured with astrocytes overexpressing or silenced for UCP4/
UCP5. Overexpression of UCP4 or UCP5 in astrocytes
increased the neuronal survival by nearly 20–35% compared
with control astrocytes (Fig. 7C, black columns). In contrast,
UCP4 or UCP5 silencing in astrocytes reduced significantly the
viability of co-cultured neurons by 33 and 24%, respectively
(Fig. 7C, gray columns).
DISCUSSION
The decoupling of proton gradient dedicated to the produc-
tion of ATP in favor of a decrease in entropy and hence an
increase in temperature is a well described (1, 42, 43) phenom-
enon in brown adipose tissue and is caused by the presence of
UCP1 in this tissue. In brain cells, UCP1 is marginally
expressed, and its possible role in the CNS remains unclear.
The UCP2 isoform role in the brain is still debated, but it
appears to be linked either to controlling the local temperature
to increase conduction velocity (4) or to controlling ROS pro-
duction (5). Regarding this control of ROS by UCP2, this role
FIGURE 4.UCP4 enhanced the glycolytic activity of astrocyte. A, the NAD/NADH ratio was reduced in the presence of overexpressed UCP4 and increased
by UCP4 silencing. UCP5 had no significant effect on NAD/NADH. The results are means of triplicates of at least seven independent experiments. B, UCP4
overexpression increased CO2 production from the TCA cycle. No significant effects were found for UCP5 overexpression. The results are means of triplicates
of six independent experiments. Ctrl, control.
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seems to be measured not only in the CNS, but in most studied
tissues. UCP3 isoform appears to be expressed exclusively in
muscle and is found certainly in a nonspecific manner in the
brain.Our overexpression of the five isoformswith anHA tag in
astrocytes in culture was used to validate themethod of expres-
sion of the protein and also allowed confirmation that none of
the commercial antibodies directed against one or the other
UCPs isoforms was really specific.
The primary aim of this study was to elucidate the role of
UCP4 and UCP5 isoforms in the CNS. Localization of UCP4
and UCP5 in the mouse brain (16, 19) demonstrates an impor-
tant RNA expression that is likely to be translated into a func-
tional role. Brain cell metabolism is tightly regulated, and its
perturbation can lead to dysfunction and maybe to neurode-
generative diseases as discussed by Andrews et al. (44). It there-
fore becomes important to understand UCP4 and UCP5
functions, mechanisms of action, and, in particular, their
involvement in metabolism in astrocytes, given the intimate
metabolic relationship between astrocytes and neurons.
We first confirmed the earlier observation (21) that gluta-
mate leads to a stimulation of glucose uptake by 20% and found
that the same happens in astrocytes overexpressing UCP4 or
UCP5. However, when endogenous UCP4 was reduced using
sh-UCP4 (Fig. 2A), this enhancement of glucose uptake caused
by glutamate did not occur. This observation was parallel to
lactate release, which was similarly influenced by UCP4. Thus,
we hypothesized that UCP4 operates a control on respiration
(Fig. 5A) by tuning intramitochondrial pH level as we observed
(20) in the presence of glutamate.
The reduced level of glycogen in astrocytes overexpressing
UCP4 or UCP5 may be a consequence of the mitochondrial
uncoupling observed and hence to the reduction of the available
ATP in cell. One ATP is necessary to transform glucose to glu-
cose 1-phosphate, which is the first step in the glycogen synthesis.
FIGURE 5. Effects of UCP4 andUCP5onmitochondrial respiration in astrocytes.A, time course of OCR, as a percentage of basal respiration calculated from
the third time points, in the presence of overexpressed or silenced UCP4. UCP4 increased the effect of glutamate, whereas UCP4 silencing reduced it,
suggesting anUCP4-dependingmechanism of glutamate onOCR. The results aremeans of quintuplicates of one representative experiment. B, time course of
OCR without normalization. C, quantification of oxygen consumption rate. Under glutamate exposure, UCP4 overexpression reduced the OCR compared with
controlastrocytes. In thesamevein, theOCRunderglutamatewashigher inastrocytessilencedforUCP4comparedwithcontrolastrocytes.Nosignificant resultswere
found for UCP5. The results aremeans of septuplicates of six independent experiments. Ctrl, control; FCCP, carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone.
FIGURE 6.UCP4 is required for themitochondrialmatrix acidification fol-
lowing glutamate exposure. Glutamate exposure induced a mitochondrial
matrix acidification. UCP4 overexpression reduced the basal matrix pH,
whereas UCP4 silencing reduced the acidification caused by glutamate stim-
ulation, suggesting that the matrix acidification following glutamate expo-
sure is an UCP4-dependent mechanism. UCP5 had no significant effects. The
results are means of at least 10 experiments. Ctrl, control.
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At the astrocyte mitochondrial level, the effects observed
during the overexpression of UCP4 or 5 are decreased mito-
chondrial electrical potential, decreased ATP production, and
decreased H2O2 production (Fig. 8). One can deduce from
these results that overexpression of UCP4 or 5 decreases the
efficiency of oxidative phosphorylation. Under these condi-
tions, theKrebs cycle is enhanced, which results in a decrease of
the NAD/NADH ratio, and also by an increase in the CO2 pro-
duction. This increase in NADH and CO2 from the Krebs cycle
is possible because there is no exhaustion of the substrates
(ADP, NAD, and acetyl-CoA) and no negative regulation by
ATP. It also indicates that the production of reducing equiva-
lents (NADH) has not reached the threshold of inhibition as
evidenced by the accumulation of CO2 coming from the Krebs
cycle that keeps functioning.
All mitochondrial indices tested (ATP production, H2O2 pro-
duction, mitochondrial potential, and NAD/NADH ratio) were
confirmed by the opposite effects elicited by UCP4 or UCP5
FIGURE 7.AstrocyticUCP4-mediated lactate release increasedneuronal survival.A, time courseofOCR inneuronsdependingon substrate availability. Neurons
preincubated with 0.5 mM glucose increased their OCR when they received glucose lactate, but the higher OCRwas obtained with high concentration of lactate
alone. The results presented are means of quintuplicates. B, 24 h lactate released by astrocytes overexpressing or silenced for UCP4 or UCP5. UCP4 overexpression
increased lactate release,whereasUCP5overexpressionhadnosignificanteffects.On theotherhand, lactate releasedbyastrocyteswas reducedwhenUCP4orUCP5
were silenced. The results aremeans of triplicates of 10 experiments. C, neurons exposed to astrocytes overexpressing UCP4 or UCP5 showed an increased viability
comparedwithneuronsexposedtocontrolastrocytes.Ontheotherhand,neuronsexposedtoastrocytessilencedforUCP4orUCP5hadareducedviabilitycompared
with neurons exposed to control astrocytes. The results aremeans of triplicates of nine experiments. Ctrl, control;Glc, glucose; Lac, lactate.
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silencing, demonstrating the essential role ofUCPs in astrocytes in
the mitochondrial respiration control. According to the results
presented in this study, themode of action ofUCP4 onmitochon-
dria inastrocytes canbe summarized inanuncouplingofoxidative
phosphorylation. It is likely that the same applies to UCP5, also
expressed by astrocyte mitochondria.
The next issue is to identify a functional role for these UCPs.
We have previously shown (20) that astrocytes OCR decreased
by 20% following glutamate application and that this decrease
in respiration was due to mitochondrial acidification. We now
show that the decrease in pH is controlled by UCP4. Overex-
pression of UCP4 actually decreased basal intramitochondrial
pH, and glutamate application caused an additional acidifica-
tion to reach the same pH 6.6 as in the nontransfected astro-
cytes. This pH value likely represents the lower limit of matrix
acidification. This decrease in pH in all cases had the same
effect of reducing the respiration by 20%. The demonstration of
the role played by UCP4 in controlling respiration via the
intramitochondrial pH is even more striking when we reduced
the UCP4 expression. In this case, the intramitochondrial pH
drop was less pronounced in the presence of glutamate, and
respiration is consequently not decreased to the same extent.
The results of the UCP5 experiments do not allow clear-cut
conclusions regarding its mode of action. It is noteworthy that
UCP5 can be found in two different variants (9). For this study,
we cloned the full-length sequence in astrocyte; it is conceivable
that the UCP5 short variant is the form present in astrocytes,
whereas the long form is present in neurons, or the other way
round. Further investigations need to be undertaken to clarify
by which mechanism astrocyte UCP5 increases neuronal
viability.
UCP4 function would then be that of reducing astrocyte res-
piration in the presence of glutamate, through a decrease in
intramitochondrial pH. To compensate for the impaired oxida-
tive energy production, astrocytes enhance glycolysis, and
therefore their production of lactate. Lactate produced by
astrocytes is used by neurons, as demonstrated by the OCR
increase caused by lactate in neuronal cultures and has the ben-
eficial effect of enhancing their survival rate, as shown in Fig.
7C.
CONCLUSION
In summary, the release of glutamate in synapses and
reuptake by astrocytes induces a mechanism of decreased res-
piration in astrocyte, an effect mediated by UCP4, and possibly
UCP5, whose consequence is to promote energy production by
glycolysis for producing preferentially lactate that can be in
turn used by neurons (Fig. 8). Overall, control of pH by the
intramitochondrial UCP4 in astrocytes may be considered as a
mechanism that helps sustain neuronal survival. Therefore, it is
not surprising that a modification in UCP4 expression was
found at the onset of neurodegenerative diseases (11, 45, 46).
This work explains for the first time a role for the presence of
UCP4 in the brain.
FIGURE 8. Effect of astrocytic uncoupling protein on astrocyte-neuron lactate shuttle hypothesis. When UCP4 was overexpressed in astrocytes, some
metabolic changes occurred on the cell as shown by red arrows. Uncoupling activity was detected by reducedmitochondrial potential and reduced ATP/ADP
ratio. TCA cycle activity was enhanced as shown by increased NADH (decreased NAD/NADH ratio) and increased CO2 production. Astrocytes overexpressing
UCP4 had reduced H2O2 production, decreased oxygen consumption rate, and increased lactate release. In the presence of astrocytes overexpressing UCP4,
neighboring neurons survived better.
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